Hootan Melamed Introduces Effective Creams to Address Inflammation and Pain
Topical pain relief creams such as Lidocream, Ketocream, Indocream, and Gabacream are introduced and described.
Los Angeles, CA (PRWEB) April 12, 2014
Well-known compounding pharmacist and entrepreneur in Beverly Hills, Dr. Hootan Melamed, has introduced a range of proven and effective formulated creams that are designed to provide relief from inflammation and pain. In many cases, mass produced medications may not be able to provide adequate relief or may cause side effects in certain patients.
Dr. Melamed recognizes the complex medical conditions that may result in mild, acute or chronic pain, and has created a number of effective compounding solutions in the form of creams and gels that are helping a large number of patients achieve freedom from pain and inflammation. These compounded medications are available through Dr. Melamed’s Rox-San Pharmacy in Beverly Hills.
This innovative cream contains a certain percentage of lidocaine, which is a widely recognized local anesthetic with a neuron membrane stabilizing effect. Lidocream is designed to provide topical relief from pain by causing loss of feeling or numbness in the skin and mucous membranes in the affected area.
Dr. Melamed recommends his patients to use Lidocream twice a day for best results. The cream is available in two strengths to address the specific needs of different types of patients. Patients with mild to moderate pain condition may opt for Lidocream with 5 percent lidocaine, while those with more severe pain may need Lidocream with 10 percent lidocaine.
Ketocream is one of the most effective topical products from Rox-San Pharmacy to address the conditions of muscular tension, inflammation and pain. It is available in various combinations and strengths to suit the unique needs of patients. Ketocream-LC includes Ketopropen, Lidocain, and Cyclobenazepril in 10%, 5%, and 2% respectively. Ketoprofen treats inflammation and provides analgesia, cyclobenazepril treats muscle tension and lidocaine provides pain relief by blocking pain nerve signals.
Ketocream-L is available as a combination of Ketopropen and Lidocaine in the ratio of 10% and 5% respective. Ketocream-C contains Ketoprofen 20% and Cyclobenazepril 2% as it active ingredients. Ketocream-10 comprises only Ketoprofen 10% for analgesic and anti-pyretic effects. Patients who need this formulation in double strength may go for Ketocream-20, which includes Ketoprofen 20%.
The active ingredient in this cream is Indomethacin, which is a non-steroidal anti-inflammatory drug (NSAID) with analgesic and anti-pyretic properties. It is helpful in the treatment of osteoarthritis, rheumatoid arthritis, spondylitis, and other acute pains. The medication is available in two strengths: Indocream-20, which contains 20% Indomethacin and Indocream-10 with 10% Indomethacin for less severe cases of pain.
Gabacream is a highly effective topical medication available in various combinations and strengths. Gabacream-213 contains Gabapentin 3%, Ketamine 2%, and Baclofen 1% as its active ingredients. Gabapentin is an antiepileptic medication used to control seizures. It is also highly effective in treating neuropathic pain. Gabacream-24 contains Gabapentin 10%, Ketamine 10%, and Baclofen 4%.
Ketamine is used to address neuropathic pain and Baclofen is helpful in treating muscle tension and spasticity. Gabacream-4 contains Gabapentin 10%, Ketamine 10%, Ketoprofen 10%, and Lidocaine 5%. Gabacream-3 is a combination of the following active ingredients: Gabapentin 6%, Ketoprofen 10%, and Lidocaine 10%.
Dr. Melamed also provides medications such as Diclocream-20 and Diclocream-10, which include Diclofenac Sodium 20% or 10% as their active ingredient. Diclofenac is an NSAID that works by reducing hormones that cause inflammation and pain in the body. Another medication is Capasacream-5 that contains Capsaicin 0.05% along with Menthol and Camphor. It provides temporary relief from neuropathic pain, diabetic neuropathy, osteoarthritis, and rheumatoid arthritis.
For the original version on PRWeb visit: http://www.prweb.com/releases/2014/04/prweb11754493.htm